Basics Bicycle Therapeutics plc IPO Date: May 20, 2019 Sector: Healthcare Industry: Biotech Market Cap: $595.58M Activated in VL: True Average Daily Range Avg Daily Range: $0.65 | 3.02% Avg Daily Range (30 D): $0.30 | 3.82% Avg Daily Range (90 D): $0.30 | 3.02% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .38M Avg Daily Volume (90 D): .29M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 97 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 1,045 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $1.2M Avg Inst. Trade (90 D): $2.13M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.19M Avg Closing Trade (30 D): $.52M Avg Closing Trade (90 D): $.56M Avg Closing Volume: 45.28K         News Mar 3, 2025 @ 6:00 PM Advanced Urothelial Carcinoma Clinical Trial Pipel... Source: Delveinsight Jun 27, 2024 @ 1:40 PM Are Medical Stocks Lagging Bicycle Therapeutics (... Source: Zacks Equity Research Jun 21, 2024 @ 12:24 PM Top 5 Small-Cap Biotechnology Stocks for a Stable ... Source: Nalak Das Jun 11, 2024 @ 1:40 PM Is Bicycle Therapeutics (BCYC) Stock Outpacing Its... Source: Zacks Equity Research May 24, 2024 @ 4:25 PM Bicycle Therapeutics (BCYC) Up as PIPE Funding Set... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.14 $-.88 $-.75 Diluted EPS $-3.14 $-.88 $-.75 Revenue $ 25.72M $ 9.98M $ 3.71M Gross Profit $ $ $ Net Income / Loss $ -203.22M $ -60.75M $ -51.85M Operating Income / Loss $ -248.36M $ -70.2M $ -67.66M Cost of Revenue $ $ $ Net Cash Flow $ 335.79M $ -87.02M $ -9.56M PE Ratio